Xerostomia, xerophthalmia, and plasmacytic infiltrates of the salivary glands (Sjögren's-like syndrome) in a cat

Journal of the American Veterinary Medical Association

Volumn 218, Issue 1, 2001, Pages 59-65

  Canapp Jr , Sherman O ^a,b   Cohn, Leah A ^a   Maggs, David J ^a,c   Miller, Margaret A ^a   Kerl, Marie E ^a   O'Brien, Dennis P ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Florida College of Veterinary Medicine   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FELIS CATUS;

ANTIINFECTIVE AGENT; ATROPINE; CLINDAMYCIN; GLUCOCORTICOID; MIOTIC AGENT; MYDRIATIC AGENT; PILOCARPINE; PREDNISONE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOPSY; CASE REPORT; CAT; CAT DISEASE; CORNEA; DRUG EFFECT; DYSPHAGIA; FEMALE; LACRIMAL FLUID; PATHOLOGY; SALIVARY GLAND; SJOEGREN SYNDROME; VIDEORECORDING; XEROPHTHALMIA; XEROSTOMIA;

ANIMALS; ANTI-BACTERIAL AGENTS; ATROPINE; BIOPSY; CAT DISEASES; CATS; CLINDAMYCIN; CORNEA; DEGLUTITION DISORDERS; FEMALE; GLUCOCORTICOIDS; MIOTICS; MYDRIATICS; PILOCARPINE; PREDNISONE; SALIVARY GLANDS; SJOGREN'S SYNDROME; TEARS; VIDEOTAPE RECORDING; XEROPHTHALMIA; XEROSTOMIA;

EID: 0035219259     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2001.218.59     Document Type: Article

References (40)

1. Botelho SY, Hisada M, Fuenmayor N. Functional innervation of the lacrimal gland in the cat. Origin of secretomotor fibers in the lacrimal nerve. Arch Ophthalmol 1966;76:581-588.
2. Lee M, Rutka JA, Slomovic AR, et al. Establishing guidelines for the role of minor salivary gland biopsy in clinical practice for Sjögren's syndrome. J Rheumatol 1998;25:247-253.
3. Bloch KJ, Buchanan WW, Wohl MJ, et al. Sjögren's syndrome: a clinical, pathological, and serological study of 62 cases. Medicine (Baltimore) 1965;44:187-231.
4. Morgan W, Castleman B. A clinicopathological study of "Mikulicz's disease." Am J Pathol 1953;29:471-489.
5. Mikulicz J. Concerning a peculiar symmetrical disease of the lacrimal and salivary glands. Med Classics 1937;2:165-186.
6. Bell M, Askari A, Bookman A, et al. Sjögren's syndrome: a critical review of clinical management. J Rheumatol 1999;26:2051-2061.
7. Quimby FW, Schwartz RS, Poskitt T, et al. A disorder of dogs resembling Sjögren's syndrome. Clin Immunol Immunopathol 1979;12:471-476.
8. Fox RI, Robinson CA, Curd JG, et al. Sjögren's syndrome: proposed criteria for classification. Arthritis Rheum 1986;29:577-585.
9. Kohler PF, Winter ME. A quantitative test for xerostomia: the Saxton test, an oral equivalent of the Schirmer test. Arthritis Rheum 1985;28:1128-1132.
10. Fox RI, Howell FV, Bone RC, et al. Primary Sjögren syndrome: clinical and immunopathologic features. Semin Arthritis Rheum 1984;14:77-105.
11. Wiseman LR, Faulds D. Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia. Drugs 1995;49:143-155.
12. Vivino FB, Katz WA. Sjögren's syndrome: clinical picture and diagnostic tests. J Musculoskel Med 1995;12:40-52.
13. Guilford WG, O'Brien DP, Allert A, et al. Diagnosis of dysautonomia in a cat by autonomic nervous system function testing. J Am Vet Med Assoc 1988;193:823-828.
14. Fox RI, Tornwall J, Michelson P. Current issues in the diagnosis and treatment of Sjögren's syndrome. Curr Opin Rheumatol 1999;11:364-371.
15. Veith LA, Cure TH, Gelatt KN. The Schirmer tear test - in cats. Mod Vet Pract 1970;51:48-49.
16. Nasisse MP, Guy JS, Davidson MG, et al. Experimental ocular herpesvirus infection in the cat. Sites of viral replication, clinical features, and effects of corticosteroid administration. Invest Ophthalmol Vis Sci 1989;30:1758-1768.
17. Arnett BD, Brightman AH, Musselman EE. Effect of atropine sulfate on tear production in the cat when used with ketamine hydrochloride and acetylpromazine maleate. J Am Vet Med Assoc 1984;185:214-215.
18. Gillette EL, LaRue SM, Gillette SM. Normal tissue tolerance and management of radiation injury. Semin Vet Med Surg (Small Anim) 1995;10:209-213.
19. Maggs DJ, Lappin MR, Reif JS, et al. Evaluation of serologic and viral detection methods for diagnosing feline herpesvirus-1 infection in cats with acute respiratory tract or chronic ocular disease. J Am Vet Med Assoc 1999;214:502-507.
20. Forstot JZ, Forstot SL, Greer RO, et al. The incidence of Sjögren's sicca complex in a population of patients with keratoconjunctivitis sicca. Arthritis Rheum 1982;25:156-160.
21. Markusse HM, Hogeweg M, Swaak AJ, et al. Ophthalmological examinations of patients with primary Sjögren's syndrome selected from a rheumatological practice. Br J Rheumatol 1992;31:473-476.
22. Longshore RC, O'Brien DP, Johnson GC, et al. Dysautonomia in dogs: a retrospective study. J Vet Intern Med 1996;10:103-109.
23. Moutsopoulos HM. Sjögren's syndrome therapy: future directions. J Rheumatol 1997;24(suppl 50):33-34.
24. Escudero D, Latorre P, Codina M, et al. Central nervous system disease in Sjögren's syndrome. Ann Med Interne (Paris) 1995;146:239-242.
25. Hayden DW, Barnes DM, Johnson KH. Morphologic changes in the mammary gland of megestrol acetate-treated and untreated cats: a retrospective study. Vet Pathol 1989;26:104-113.
26. Daniels TE. Labial salivary gland biopsy in Sjögren's syndrome-assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984;27:147-156.
27. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-347.
28. Lindahl G, Hedfors E. Focal lymphocytic infiltrates of salivary glands are not confined to Sjögren's syndrome. Scand J Rheumatol Suppl 1986;61:52-55.
29. Manoussakis MN, Tzioufas AG, Pange PJE, et al. Serological profiles in subgroups of patients with Sjögren's syndrome. Scand J Rheumatol Suppl 1986;61:89-92.
30. Atkinson JC, Travis WD, Slocum L, et al. Serum and SS-B/La and IgA rheumatoid factors are markers of salivary gland disease activity in primary Sjögren's syndrome. Arthritis Rheum 1992;35:1368-1371.
31. Masunaga H, Ogawa H, Uematsu Y, et al. Long-lasting salivation induced by a novel muscarinic receptor agonist SN1-2011 in rats and dogs. Eur J Pharmacol 1997;339:1-9.
32. Vivino FB, Al-Hashimi I, Kahn Z, et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. Arch Intern Med 1999;159:174-181.
33. Papas AS, Fernandez MM, Castano RA, et al. Oral pilocarpine for symptomatic relief of dry mouth and dry eyes in patients with Sjögren's syndrome. Adv Exp Med Biol 1998;438:973-978.
34. Williams DL. A comparative approach to topical cyclosporine therapy. Eye 1997;11:453-464.
35. Palmer SL, Bowen A, Green K. Tear flow in cyclosporine recipients. Ophthalmology 1995;102:118-121.
36. Kaswan RL, Salisbury MA, Ward D. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops. Arch Ophthalmol 1989;107:1210-1216.
37. Brignole F, Pisella PJ, Goldschild M, et al. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci 2000;41: 1356-1363.
38. Gunduz K, Ozdemir O. Topical cyclosporine as an adjunct to topical acyclovir treatment in herpetic stromal keratitis. Ophthalmic Res 1997;29:405-408.
39. Halford WP, Schaffer PA. Optimized viral dose and transient immunosuppression enable herpes simplex virus ICPO-null mutants to establish wild-type levels of latency in vivo. J Virol 2000;74: 5957-5967.
40. Monier JC, Fournel C, Lapras M, et al. Systemic lupus erythematosus in a colony of dogs. Am J Vet Res 1988;49:46-51.